Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
The American Journal of Cardiology|January 31, 2006
Effectiveness of "direct" stenting without balloon predilatation (from the Multilink Tetra Randomised European Direct Stent Study [TRENDS])Keith D Dawkins, Bernard Chevalier, Marten-Jan Suttorp, et al.
The American Journal of Cardiology|January 7, 2016
One-Year Outcomes in "Real-World" Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study [PE-Plus PAS])David E Kandzari, Nima Amjadi, Christopher Caputo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 16, 2013
Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trialArie Pieter Kappetein, Stuart J Head, Marie-Claude Morice, et al.
JACC. Cardiovascular Interventions|May 21, 2011
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial ProgramGregg W Stone, Stephen G Ellis, Antonio Colombo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2009
The European cobalt STent with Antiproliferative for Restenosis trial (EuroSTAR): 12 month resultsKeith D Dawkins, Stefan Verheye, Helmut Schühlen, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 25, 2006
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phaseArie Pieter Kappetein, Keith D Dawkins, Friedrich W Mohr, et al.
The American Journal of Cardiology|August 2, 2011
Propensity-matched patient-level comparison of the TAXUS Liberté and TAXUS element (ION) paclitaxel-eluting stentsDean J Kereiakes, Louis A Cannon, John A Ormiston, et al.
The American Journal of Cardiology|February 18, 2014
Three-year results comparing platinum-chromium PROMUS element and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing (from the PLATINUM Trial)Ian T Meredith, Paul S Teirstein, Alain Bouchard, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 30, 2015
PLATINUM China: a prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesionsRunlin Gao, Yaling Han, Yuejin Yang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Integrated analysis of medically treated diabetic patients in the TAXUS(R) program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatmentsKeith D Dawkins, Gregg W Stone, Antonio Colombo, et al.
Pageof 14